CLDX

NASDAQ · Biotechnology

Celldex Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$29.04

-1.06 (-3.52%)

As of Nov 7, 1:48 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 19 90%

Hold 2 10%

Sell 0 0%

Price Target

Analyst Price Target +79.3% upside

Low Target $39.61

Average Target $52.08

High Target $81.09

Current Price $29.04

Current
$29.04

Target
$52.08

$39.61 $52.08 avg $81.09

Scenario Analysis

Bear Case

$39.61

36.4%

Low target

Base Case

$52.08

+79.3%

Avg target

Bull Case

$81.09

+179.2%

High target

Risk/Reward

4.9x

Highly favorable

Price in Context

52-Week High

$45.14

-35.7% from high

52-Week Low

$22.10

+31.4% from low

Target vs 52W High

$52.08

+15.4% vs high

Next Earnings Report

Nov 11, 2026

until earnings

EPS Est: $-1.04

Earnings in 3 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%